Acer Medical Inc.
Founded in 2018, Acer Medical is the first subsidiary under the Acer Group to focus on preventive medicine.
Leveraging our expertise in ICT, we specialize in AI and big data analytics with a focus on Preventive Medicine. Our journey began with diagnostic medical imaging and subsequently expanded to medical device software, hardware integration solutions, and healthcare management innovations.
Through interdisciplinary collaborations across medical and healthcare sectors, we seamlessly embed AI in the medical landscape, empowering healthcare providers to enhance and realize the goals of “Health Promotion," “Disease Prevention," and “Medical Care."
AI-Assisted Ophthalmic Screening Solutions
Diabetic Retinopathy (DR) and Age-related Macular Degeneration (AMD) are both leading causes of adult blindness. VeriSee DR and VeriSee AMD act as a virtual ophthalmologist, assisting the healthcare professional to quickly and accurately screen for DR and AMD. When the patient takes the fundus images, these two AI software can detect and analyze new images in real-time, giving recommendations in less than 1 minute with 93% and 95% accuracy, respectively.
Chest X-ray x Bone Mineral Density abnormalities screening: new insights of SaMD
Osteoporosis is a common disease all over the world. However, it is mostly diagnosed after a bone fracture. After bone fracture with osteoporosis, the mortality rate is about 20%, and most of them cannot take care of themselves. Chest X-ray is commonly used for physical examination and clinical diagnosis. Our AI software, VeriOsteo OP, is more convenient than other screening tools and with nearly 90% accuracy. One-step analysis within 3 seconds per chest X-ray image, and the result includes dichotomy (T-score ≦ -2.5), bone mineral density (BMD), and T-score value. This information assists healthcare professionals in assessing the risk of BMD abnormalities, enabling them to make informed decisions regarding referrals.
Product
VeriSee DR, AI-Assisted Diagnostic Software for Diabetic Retinopathy
VeriSee DR is an AI-assisted diagnostic software for diabetic retinopathy (DR) that analyzes the image for signs of diabetic retinopathy and identifies high-risk DR patients. The product uses AI which has been trained from images labeled by retina specialists, to provide suggestions for the classification of diabetic retinopathy (Regular tracking or Referral recommended) to assist healthcare providers in diagnosing DR, with a screening accuracy of 93%. In addition, the product detects four main lesions of DR, including microaneurysms, hemorrhages, soft exudates, and hard exudates, and shows the corresponding locations.
VeriOsteo OP, AI-assisted screening software for bone mineral density abnormalities
VeriOsteo OP is the first AI-assisted screening software for bone mineral density (BMD) abnormalities approved by Taiwan FDA. By analyzing “chest X-ray images”, it predicts the BMD, calculates the T-score from the BMD, and automatically outputs a recommendation on BMD abnormalities with nearly 90% accuracy.
VeriSee AMD, AI Screening Software for Age-Related Macular Degeneration
VeriSee AMD is an AI-assisted screening software for age-related macular degeneration (AMD) that identifies high-risk AMD patients. VeriSee AMD has been trained from images labeled by retina specialists and has a screening accuracy of 95%, which is comparable to ophthalmologists. It is an effective solution that can expedite the screening process, increase the volume of screenings, and improve patient outcomes.
ARC-1000, Non-Mydriatic Automated Portable Fundus Camera
ARC-1000 is a fully automated, non-dilated, portable fundus camera. It is Compatible with VeriSee DR and VeriSee AMD. Users can independently operate it on the same side, capturing retinal images quickly and easily
(1)Portable Non-Mydriatic retina camera
(2)Automatic Image Capture (within 1 minutes)
(3)12 Million Pixel
(4)Easy to Selfie